Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gabapentin may be effective in relieving pain and other symptoms of peripheral
neuropathy. It is not yet known if gabapentin is effective in treating peripheral neuropathy
in cancer patients undergoing chemotherapy.
PURPOSE: Randomized phase III trial to determine the effectiveness of gabapentin in treating
pain and other symptoms of peripheral neuropathy in cancer patients undergoing chemotherapy.